BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26386815)

  • 21. Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years.
    Acero Fernández D; Ferri Iglesias MJ; Buxó Pujolràs M; López Nuñez C; Serra Matamala I; Queralt Molés X; Aldeguer Manté X
    Gastroenterol Hepatol; 2018 Jan; 41(1):2-11. PubMed ID: 29150360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users.
    Strasfeld L; Lo Y; Netski D; Thomas DL; Klein RS
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):356-64. PubMed ID: 12843747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of occult HCV infection among Hiv infected patients in Georgia.
    Gatserelia L; Sharvadze L; Karchava M; Dolmazashvili E; Tsertsvadze T
    Georgian Med News; 2014 Jan; (226):37-41. PubMed ID: 24523330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey.
    Davaalkham D; Ojima T; Nymadawa P; Uehara R; Watanabe M; Oki I; Nakamura Y
    J Med Virol; 2006 Apr; 78(4):466-72. PubMed ID: 16482536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.
    Rao H; Wei L; Lopez-Talavera JC; Shang J; Chen H; Li J; Xie Q; Gao Z; Wang L; Wei J; Jiang J; Sun Y; Yang R; Li H; Zhang H; Gong Z; Zhang L; Zhao L; Dou X; Niu J; You H; Chen Z; Ning Q; Gong G; Wu S; Ji W; Mao Q; Tang H; Li S; Wei S; Sun J; Jiang J; Lu L; Jia J; Zhuang H
    J Gastroenterol Hepatol; 2014 Mar; 29(3):545-53. PubMed ID: 24090188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV infection in voluntary donors and its influence on recruitment of donors in Chongqing area.
    Zhao SM; Jiang TL; Li RQ; Gao FX; Lu L; Zheng HQ; Hu J; Fan YH; Li B; Xiao RQ; Yury K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):676-80. PubMed ID: 18549653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of Hepatitis C Virus infection among people who use crack cocaine in an important international drug trafficking route in Central-West Region Brazil.
    Castro VOL; Kamili S; Forbi JC; Stabile AC; da Silva EF; do Valle Leone de Oliveira SM; de Carvalho PRT; Puga MAM; Tanaka TSO; do Lago BV; Ibanhes ML; Araujo A; Tejada-Strop A; Lin Y; Xia GL; Sue A; Teles SA; Motta-Castro ARC
    Infect Genet Evol; 2020 Nov; 85():104488. PubMed ID: 32745809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
    Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
    Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological characteristics and risk factors of hepatitis C virus genotype 1 infection: a national epidemiological survey of Chinese Han population.
    Wang CB; Cheng ZX; Chen JJ; Chen YY; Nie HM; Ling QH; Dong YN
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1052-6. PubMed ID: 27049256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
    Armstrong GL; Wasley A; Simard EP; McQuillan GM; Kuhnert WL; Alter MJ
    Ann Intern Med; 2006 May; 144(10):705-14. PubMed ID: 16702586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors of HCV infection in Poland.
    Flisiak R; Halota W; Horban A; Juszczyk J; Pawlowska M; Simon K
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1213-7. PubMed ID: 22002000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on epidemiology of hepatitis B and C in China.
    Cui Y; Jia J
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():7-10. PubMed ID: 23855289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
    Meffre C; Le Strat Y; Delarocque-Astagneau E; Dubois F; Antona D; Lemasson JM; Warszawski J; Steinmetz J; Coste D; Meyer JF; Leiser S; Giordanella JP; Gueguen R; Desenclos JC
    J Med Virol; 2010 Apr; 82(4):546-55. PubMed ID: 20166185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey.
    Tan YW; Tao Y; Liu LG; Ye Y; Zhou XB; Chen L; He C
    World J Gastroenterol; 2018 Mar; 24(11):1250-1258. PubMed ID: 29568205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.